Avicenna is keen to support research and development programmes of clinicians, academic institutions, small biotechnology companies, and medical research organisations.  Our goal is to build upon our existing catalogue of product development candidates and to establish a unique proprietary pipeline.  Avicenna will selectively choose to partner with organisations that have therapeutic expertise in relevant disease areas and a significant commitment to development and commercialisation of novel drug candidates.  Avicenna has a particular interest in exploring candidates for immunological therapies.
 
Avicenna is also open to co-development opportunities for its existing pipeline. We strongly believe that the early association of strategic partners in the development process will significantly enhance the value created.

To learn more about partnering opportunities with Avicenna, please contact our operations team.